Safety of omitting defibrillation efficacy testing with subcutaneous defibrillators: a propensity matched case-control study

24 April 2021 (19:20 - 20:20)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Valter Bianchi

AO dei Colli - Monaldi Hospital, Naples (Italy)

7 More presentations in this session

Presentation thumbnail

Five year outcomes of the subcutaneous implantable cardioverter-defibrillator EFFORTLESS (evaluation of factors impacting clinical outcome and cost effectiveness of the S-ICD) registry

Professor P. Lambiase (London, GB)

Abstract Slides Video

Presentation thumbnail

Accelerometry-assessed physical behaviour and the association with clinical outcomes in implantable cardioverter-defibrillator recipients: a systematic review.

Mr M. Kolk (Amsterdam, NL)

Abstract Slides Video

Presentation thumbnail

Subcutaneous and single-chamber transvenous defibrillators: a nationwide matched control study.

Doctor A. Bodin (Chambray Les Tours, FR)

Abstract Slides Video

Presentation thumbnail

Prognostic impact of subcutaneous implantable cardioverter-defibrillator appropriate and inappropriate shocks

Doctor L. Oliveira (Ponta Delgada, PT)

Abstract Slides Video

Presentation thumbnail

Serratus anterior plane block reduces perioperative sedation use and discharge analgesia in subcutaneous implantable defibrillator implantation

Doctor A. Mistry (Nottingham, GB)

Abstract Slides Video

Access the full session

Session thumbnail

News from ICD therapy

The Event

EHRA 2021

24 April 2021 19:20 CET

You may be interested in

Congress Session

Debate on primary prevention in ICD therapy

Congress Session

Implantable cardioverter defibrillator therapy

Congress Session

Hot topics in the management of ventricular tachycardia and sudden cardiac death

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources